Cargando…
MYC selects against reduced BCL2A1/A1 protein expression during B cell lymphomagenesis
Rearrangements of MYC or ABL proto-oncogenes lead to deregulated expression of key-regulators of cell cycle and cell survival, thereby constituting important drivers of blood cancer. Members of the BCL-2 family of apoptosis regulators contribute to oncogenic transformation downstream of these oncoge...
Autores principales: | Sochalska, M, Schuler, F, Weiss, J G, Prchal-Murphy, M, Sexl, V, Villunger, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395700/ https://www.ncbi.nlm.nih.gov/pubmed/27694901 http://dx.doi.org/10.1038/onc.2016.362 |
Ejemplares similares
-
Checkpoint kinase 1 is essential for normal B cell development and lymphomagenesis
por: Schuler, Fabian, et al.
Publicado: (2017) -
Role of MYC in B Cell Lymphomagenesis
por: Korać, Petra, et al.
Publicado: (2017) -
Conditional knockdown of BCL2A1 reveals rate-limiting roles in BCR-dependent B-cell survival
por: Sochalska, M, et al.
Publicado: (2016) -
Mnt modulates Myc-driven lymphomagenesis
por: Campbell, Kirsteen J, et al.
Publicado: (2017) -
Role of the transcription factor Bcl11b in development and lymphomagenesis
por: KOMINAMI, Ryo
Publicado: (2012)